Skip to main content
Hyper Corporation Inc. logo

Hyper Corporation Inc. — Investor Relations & Filings

Ticker · 065650 ISIN · KR7065650004 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 391 across all filing types
Latest filing 2024-03-07 Proxy Solicitation & In…
Country KR South Korea
Listing KO 065650

About Hyper Corporation Inc.

https://hyper-corp.com/

Hyper Corporation Inc. is a company transitioning from a clinical-stage biopharmaceutical firm to a new-tech-based platform provider. Its core Bio & Healthcare division develops treatments and diagnostic technologies for neurodegenerative diseases like Alzheimer's, aiming to build a comprehensive digital senior healthcare platform. The company is expanding by integrating AI and blockchain technologies into new sectors. Its IP & Content division focuses on securing intellectual property and innovating content distribution, while its New Tech division develops platforms to connect online and offline services. This strategy fuses its biotechnology expertise with advanced IT to create new business models and services.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) filed by Medifron. It details the date, location, and specific agenda items (such as director appointments, auditor appointments, and business purpose changes) for an upcoming Annual General Meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda, which falls under the Proxy Solicitation & Information Statement category.
2024-03-07 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Medifron) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea (KRX) to report financial performance fluctuations. Since it provides key financial highlights and reasons for the change rather than being a full annual report or a simple announcement of a report's availability, it falls under the category of Earnings Release (ER) as it serves as the initial announcement of financial results. FY 2023
2024-03-07 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds issued by Medifron. This type of filing details changes to the capital structure and financial obligations of the company, specifically relating to the conversion price of debt instruments into equity. Under the provided categories, this falls under 'Capital/Financing Update' (CAP) as it pertains to financing activities and capital structure adjustments.
2024-02-26 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. It details a change in shareholding (specifically a new acquisition via a stock purchase agreement) by FSN Co., Ltd. in Medifron DBT. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership changes crossing reporting thresholds.
2024-02-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by FSN Co., Ltd. in Medifron DBT, crossing the reporting threshold. This document type is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-02-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications, changes in management control, and contractual agreements related to share transfers. This fits the definition of a Major Shareholding Notification (MRQ).
2024-02-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.